Presentations

9th IAS Conference on HIV Science held on July 23-26, 2017 at Paris, France

July 23, 2017
  1. Teeraananchai S, Kerr S, Prasitsuebsai W, Do VC, Nguyen LV, Le TPK, Kosalaraksa P, Singtoroj T, Jupimai T, Thammajaruk N, Gandhi M, Sohn AH, TASER-Pediatrics study. Viral resuppression and persistent failure after viremia on second-line antiretroviral treatment among Asian children and adolescents.
  2. Teeraananchai S, Bunupuradah T, Puthanakit T, Kerr SJ, Ruxrungtham K, Chaivooth S, Bhakeecheep S, Law MG, Chokephaibulkit K. First line antiretroviral treatment outcomes and durability in HIV-infected children treated through the universal coverage health program in Thailand.
  3. Jiamsakul A, Kerr SJ, Kiertiburanakul S, Azwa I, Zhang F, Chaiwarith R, Wong W, Sun LP, Kumarasamy N, Ditangco R, Pujari S, Yunihastuti E, Cuong DD, Merati TP, Nguyen VK, Lee MP, Choi JY, Oka S, Kantipong P, Sim BLH, Ng OT, Ross J, Law M, on behalf of the TREAT Asia HIV Observational Database (TAHOD). Early suboptimal ART adherence predicts missed clinic visits over five years in Asia.
  4. Koss C, Bacchetti P, Teeraananchai S, Kerr S, Prasitsuebsai W, Singtoroj T, Kuncze K, Jin C, Alexander Louie, Horng H, Sohn A, Gandhi M. Lopinavir Hair Concentrations Predict Viremic Episodes in HIV-infected Asian Children and Adolescents on Second-line ART.
  5. Sricharoenchai S, Bunupuradah T, Hansudewechakul R, Hanh DLD, Tran DNH, Kerr S, Chalermchockcharoenkit A, Teeratakulpisarn N, Achalapong J, Dung DNY, Termrungruanglert W, Chaithongwongwatthana S, Singtoroj T, Pankam T, Phanuphak N, Sohn AH, Chokephaibulkit K, on behalf of TA008 study team. High-risk vaccine-specific HPV infection in HIV-infected and HIV-uninfected, vaccine-naïve Asian female adolescents. (oral presentation)
  6. Gatechompol S, Avihingsanon A, Apornpong T, Kerr SJ, Ruxrungtham K. Switching to rilpivirine from first-line regimens is safe and effective in resource-limited settings. Poster A-854-0109-03489
  7. Kingkaew W, Anugulruengkitt S, Jantarabenjakul W, Phonphithak S, Kasipong N, Bureechai S, Thamsala S, Sophonphan J, Bunupuradah T, Puthanakit T and on behalf of HIV-NAT 015 study team. A study of non-disclosure and associated factors among perinatal HIV-infected children and adolescents in Bangkok, Thailand.
  8. Thepnarong N, Puthanakit T, Chaithongwongwatthana S, Anugulruengkitt S, Anunsittichai O, Theerawit T, Ubolyam S, Pancharoen C, Phanuphak P. Intensification of antiretroviral treatment with raltegravir for late-presenting HIV-infected pregnant women. Oral presentation (WEACO202)